{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:56:09Z","timestamp":1782489369044,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jconrel.2020.05.017","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T21:31:25Z","timestamp":1589319085000},"page":"238-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment"],"prefix":"10.1016","volume":"324","author":[{"given":"Eren","family":"Aytekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naile","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130mran","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Kerem","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Basri","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"\u00c7al\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel Bozda\u011f","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.05.017_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.patbio.2014.10.004","article-title":"A genetic anomaly of oriented collagen biosynthesis and cross-linking: keratoconus","volume":"63","author":"Bourges","year":"2015","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/eye.2015.63","article-title":"Keratoconus: an inflammatory disorder?","volume":"29","author":"Galvis","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0039-6257(84)90094-8","article-title":"Keratoconus and related noninflammatory corneal thinning disorders","volume":"28","author":"Krachmer","year":"1984","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0039-6257(97)00119-7","article-title":"Keratoconus","volume":"42","author":"Rabinowitz","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/bjo.2010.185868","article-title":"Management of keratoconus: current scenario","volume":"95","author":"Jhanji","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9394(63)91645-3","article-title":"Electron microscope study of the pathology of keratoconus: part I","volume":"55","author":"Teng","year":"1963","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.exer.2007.12.002","article-title":"Assessment of the epithelium\u2019s contribution to corneal biomechanics","volume":"86","author":"Elsheikh","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exer.1997.0410","article-title":"Induction of cross-links in corneal tissue","volume":"66","author":"Spoerl","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","article-title":"Riboflavin\/ultraviolet-A\u2013induced collagen crosslinking for the treatment of keratoconus","volume":"135","author":"Wollensak","year":"2003","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jcrs.2008.02.002","article-title":"Effect of complete epithelial debridement before riboflavin\u2013ultraviolet-a corneal collagen crosslinking therapy","volume":"34","author":"Hayes","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/17469899.2014.927310","article-title":"Corneal cross-linking","volume":"9","author":"Alkharashi","year":"2014","journal-title":"Exp. Rev. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.optom.2013.12.001","article-title":"Corneal collagen cross-linking: a review","volume":"7","author":"O\u2019Brart","year":"2014","journal-title":"J. Opt."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/eye.2014.230","article-title":"Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus","volume":"29","author":"Shalchi","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00347-008-1783-2","article-title":"Kollagenvernetzung mit Riboflavin und UVA-Licht bei Keratokonus\u2013Dresdner Ergebnisse","volume":"106","author":"Hoyer","year":"2009","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajo.2009.10.021","article-title":"Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study","volume":"149","author":"Caporossi","year":"2010","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00417-012-2133-2","article-title":"Visual recovery after corneal crosslinking for keratoconus: a 1-year follow-up study","volume":"251","author":"Guber","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0031-1273403","article-title":"Corneal riboflavin\/UV-A collagen cross-linking (CXL) in keratoconus: two-year results","volume":"228","author":"Kampik","year":"2011","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.exer.2014.06.001","article-title":"BAC-EDTA transepithelial riboflavin-UVA crosslinking has greater biomechanical stiffening effect than standard epithelium-off in rabbit corneas","volume":"125","author":"Torricelli","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/02713683.2010.481068","article-title":"Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA\/riboflavin corneal collagen cross-linking","volume":"35","author":"Kissner","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcrs.2011.08.030","article-title":"Transepithelial corneal collagen crosslinking: bilateral study","volume":"38","author":"Filippello","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ICO.0000000000000699","article-title":"Transepithelial corneal cross-linking with vitamin E-enhanced riboflavin solution and abbreviated, low-dose UV-A: 24-month clinical outcomes","volume":"35","author":"Caruso","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2014.06.007","article-title":"Enhancement in corneal permeability of riboflavin using calcium sequestering compounds","volume":"472","author":"Morrison","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0120","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/mp3005963","article-title":"Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability","volume":"10","author":"Morrison","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1167\/iovs.16-20813","article-title":"Biomechanical strengthening of the human cornea induced by nanoplatform-based transepithelial riboflavin\/UV-A corneal cross-linking","volume":"58","author":"Labate","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/1061186X.2012.716845","article-title":"Nanostructured lipid carriers system: recent advances in drug delivery","volume":"20","author":"Iqbal","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2012.08.021","article-title":"Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study","volume":"102","author":"Tian","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0145","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1002\/jps.23251","article-title":"Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability","volume":"101","author":"Liu","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system","volume":"403","author":"Luo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","article-title":"Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine a: improving in vivo ocular distribution","volume":"402","author":"Shen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1590\/S0103-50532005000700013","article-title":"Chromatographic determination of riboflavin in the presence of tetracyclines in skimmed and full cream milk using fluorescence detection","volume":"16","author":"Silva","year":"2005","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5935\/0004-2749.20160052","article-title":"The effects of riboflavin and ultraviolet light on keratocytes cultured in vitro","volume":"79","author":"Covre","year":"2016","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7555\/JBR.29.20130173","article-title":"Impact of crosslinking\/riboflavin-UVA-photodynamic inactivation on viability, apoptosis and activation of human keratocytes in vitro","volume":"29","author":"Stachon","year":"2015","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0180","doi-asserted-by":"crossref","first-page":"45861","DOI":"10.1038\/srep45861","article-title":"Riboflavin deficiency induces a significant change in proteomic profiles in HepG2 cells","volume":"7","author":"Xin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0190","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/opo.12032","article-title":"Corneal cross-linking\u2013a review","volume":"33","author":"Meek","year":"2013","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0205","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2147\/IJN.S190502","article-title":"Natamycin solid lipid nanoparticles\u2013sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization","volume":"14","author":"Khames","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/scipharm86020016","article-title":"Ocular delivery system for propranolol hydrochloride based on nanostructured lipid carrier","volume":"86","author":"Zadeh","year":"2018","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2015.12.033","article-title":"Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique","volume":"140","author":"Peres","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4103\/0250-474X.108419","article-title":"Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride","volume":"74","author":"Shah","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0225","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.12.037","article-title":"Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size","volume":"424","author":"Ghadiri","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0230","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1039\/b9nj00754g","article-title":"RNA structural motifs that entail hydrogen bonds involving sugar\u2013phosphate backbone atoms of RNA","volume":"34","author":"Ulyanov","year":"2010","journal-title":"New J. Chem."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0235","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.70.12.3857","article-title":"The binding of riboflavin-5\u2032-phosphate in a flavoprotein: flavodoxin at 2.0-\u00c5 resolution","volume":"70","author":"Watenpaugh","year":"1973","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0240","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0245","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1167\/iovs.13-13703","article-title":"Pharmacologic alternatives to riboflavin photochemical corneal cross-linking: a comparison study of cell toxicity thresholds","volume":"55","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0250","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1111\/aos.12884","article-title":"A study of stromal riboflavin absorption in ex vivo porcine corneas using new and existing delivery protocols for corneal cross-linking","volume":"94","author":"Hayes","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2012.02.014","article-title":"M\u00f6ller, biopharmaceutics, novel micelle carriers for cyclosporin a topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies","volume":"81","author":"Di Tommaso","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0260","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Pharmacology, size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology","volume":"211","author":"Andr\u00e9s-Guerrero","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/ICL.0000000000000242","article-title":"The evaluation of corneal fragility after uva\/riboflavin crosslinking","volume":"43","author":"Li","year":"2017","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jconrel.2020.05.017_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/404587","article-title":"Imaging mass spectrometry by matrix-assisted laser desorption\/ionization and stress-strain measurements in iontophoresis transepithelial corneal collagen cross-linking","author":"Vinciguerra","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0280","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1755-3768.2008.01190.x","article-title":"Long-term biomechanical properties of rabbit cornea after photodynamic collagen crosslinking","volume":"87","author":"Wollensak","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.05.017_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066408","article-title":"Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking","volume":"8","author":"Bottos","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920302947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920302947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:49:02Z","timestamp":1759160942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920302947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":57,"alternative-id":["S0168365920302947"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.05.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}